★ Sign in to follow
JL

Johan Living

SE·Finansinspektionen
Lipigon Phartmaceuticals ABLipigon Pharmaceuticals AB
Insider activity · 24 months1 buy11 salesCumulative net flow
Total declarations
12
Companies
2
▲ Purchases (1 ops.)
€4,475
▼ Sales (11 ops.)
€6,629

Latest filing published 28 Jul 2025 for Lipigon Pharmaceuticals AB, €36.

Filing timeline

BuySale
Johan Living

Insider track record

Disclosed buys
1
Disclosed sells
11
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Johan Living: trading record in brief

Johan Living is a declared insider at 2 companies; the most frequent names are Lipigon Pharmaceuticals AB and Lipigon Phartmaceuticals AB. Over a trading history stretching from 16 December 2024 to 25 July 2025, the count stands at 12 filings.

The open-market side counts 1 purchase for €4,475 alongside 11 sales for €6,629. Taken together, the sales exceed the purchases by €2,154. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: no purchases and 11 sales on the market.

The latest filing, published on 28 July 2025, reports an open-market sale of €43 in Lipigon Pharmaceuticals AB. The last purchase on record was published on 16 December 2024, which is 692 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Johan Living

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    403 SEK22FI-SE
    2,800 shares@ SEK 0.1440.5% of flowAktieISIN SE0015382072FI:csv-b9964853f9af1f133f40
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    7,200 SEK23FI-SE
    50,000 shares@ SEK 0.1449.7% of flowAktieISIN SE0015382072FI:csv-fa6012fb9150fe8e6e56
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    294 SEK22FI-SE
    2,043 shares@ SEK 0.1440.4% of flowAktieISIN SE0015382072FI:csv-228682348888ab7153cd
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    34,668 SEK27FI-SE
    252,128 shares@ SEK 0.137546.7% of flowAktieISIN SE0015382072FI:csv-26a5654919d085c6faec
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    693 SEK22FI-SE
    5,000 shares@ SEK 0.13850.9% of flowAktieISIN SE0015382072FI:csv-cac2700dc16ae324ff16
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    4,000 SEK23FI-SE
    28,880 shares@ SEK 0.13855.4% of flowAktieISIN SE0015382072FI:csv-73c429cc494893ad40e9
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    2,800 SEK22FI-SE
    20,216 shares@ SEK 0.13853.8% of flowAktieISIN SE0015382072FI:csv-51f9905952f6177026d6
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    3,145 SEK22FI-SE
    22,704 shares@ SEK 0.13854.2% of flowAktieISIN SE0015382072FI:csv-e15545d41bf1b03f0f5f
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    1,395 SEK22FI-SE
    10,000 shares@ SEK 0.13951.9% of flowAktieISIN SE0015382072FI:csv-1ebc3256e69186e411f9
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    19,216 SEK25FI-SE
    137,749 shares@ SEK 0.139525.9% of flowAktieISIN SE0015382072FI:csv-9e9e9e85d3876a9178b1
  • ▼
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Pharmaceuticals AB
    485 SEK22FI-SE
    3,480 shares@ SEK 0.13950.7% of flowAktieISIN SE0015382072FI:csv-84700e28c01d15a75e47
  • ▲
    Johan Living
    Verkställande direktör (VD)ExecutivesLipigon Phartmaceuticals AB
    51,688 SEK42FI-SE
    260,000 shares@ SEK 0.1988100.0% of flowAktieISIN SE0015382072FI:csv-6ce39c3c28ebd4b2bdef
    Canonical exit: 16 Mar 2025 (T+90)

12 of 12 declarations

Related entities

No related entities found.